Hair Restoration Minnesota: The 2026 Provider Credential Guide

Introduction: Choosing a Hair Restoration Provider in Minnesota Shouldn’t Be a Guessing Game

Hair loss is one of the most common medical concerns in the country. According to the American Academy of Dermatology, about 80 million men and women in the United States are affected by androgenetic alopecia, commonly known as hereditary hair loss. A meaningful share of those patients live in Minnesota, from the Twin Cities metro to Rochester and beyond.

Yet many Minnesota patients choose a hair restoration provider based on proximity, star ratings, or a polished surgeon bio. Those factors say little about verifiable medical credentials or regulatory transparency.

This guide offers a credential-and-evidence framework that lets patients evaluate Minnesota providers, including Hair Transplant Specialists, Shapiro Medical Group, Hair Restoration Institute of Minnesota, HairClub, and Bosley, the same way they would vet any medical specialist. It rests on three pillars:

  1. ABHRS/ISHRS credential verification
  2. FDA regulatory disclosure, especially for exosome treatments
  3. Availability of the full evidence-based treatment spectrum

The goal is a neutral, evidence-based resource rather than a marketing page.

Understanding Hair Loss in Minnesota: Why the Stakes Are High

The scale of hair loss is substantial. The National Council on Aging reports that by age 65, an estimated 53% of men and 37% of women will experience baldness. Mayo Clinic Health System notes that androgenetic alopecia affects roughly half of men.

Hair loss is not only a male concern. The American Hair Loss Association reports that women constitute 40% of American hair loss sufferers. Surgical data reflects this shift: according to the International Society of Hair Restoration Surgery (ISHRS) 2025 Practice Census, the number of female surgical patients treated in 2024 increased by 16.5% from 2021, and women represented 15.3% of all surgical hair restoration patients globally, up from 12.7%.

For Minnesota, these trends mean more local patients, including a growing proportion of women, are seeking care. That makes it more important to choose a provider with verifiable expertise across multiple conditions and patient types.

Why “Best Reviews” and “Closest Location” Aren’t Enough

Star ratings and testimonials measure patient experience and satisfaction. They do not measure clinical competence, diagnostic accuracy, or regulatory compliance. A clinic can earn strong reviews for friendly staff while offering treatments with limited evidence or unclear regulatory status.

Many Minnesota provider websites rely on surgeon biographies or broad “one-stop-shop” service lists without explaining what separates a credentialed specialist from a general provider. What is often missing is a verifiable credential framework that patients can apply consistently.

This guide does not rank providers by subjective opinion. It applies documented, checkable standards that any patient can replicate.

The Minnesota Buyer’s Framework: Three Questions Every Patient Should Ask

The following three questions form the core framework used throughout this guide and for any future provider research.

Question 1: Does the Provider Meet the ABHRS/ISHRS Credential Bar?

The American Board of Hair Restoration Surgery (ABHRS) reports that only approximately 270 hair restoration surgeons worldwide have achieved Diplomate status. Earning it requires demonstrated training, post-training experience, aesthetic skill, and clinical understanding of hair loss treatment modalities.

ISHRS membership alone is not equivalent to board certification. Fewer than 23% of ISHRS members hold ABHRS Diplomate status, and membership generally requires only dues payment.

Patients should distinguish between generic “board-certified” marketing language and verifiable credentials such as:

  • ABHRS Diplomate status
  • ISHRS fellowship or leadership roles
  • Published, peer-reviewed research

Leadership roles within ISHRS, such as serving as Society President, represent a distinct tier of peer-recognized authority beyond general membership or board certification claims.

Question 2: Does the Provider Disclose FDA Regulatory Status on Treatments Like Exosomes?

Exosome therapy is a popular add-on at many Minnesota clinics. However, the FDA has not approved any exosome product for any condition, including hair loss. In 2019, the FDA issued a public safety notification after patients developed serious infections from an unapproved injected exosome product.

FDA disclosure is a transparency test. Trustworthy providers clearly state when a treatment is offered outside FDA approval rather than presenting it as a proven, regulated therapy.

By contrast, low-level laser therapy (LLLT), minoxidil, and finasteride have documented regulatory pathways that patients can independently verify.

Question 3: Does the Provider Offer the Full Evidence-Based Treatment Spectrum?

The full spectrum standard includes FUE, FUT, SMP, PRP, LLLT, and medical therapy (finasteride and minoxidil) under one roof. This allows treatment plans tailored to a diagnosis rather than built around a single proprietary technique.

Mayo Clinic advises working with a board-certified physician trained and experienced in hair loss treatment to ensure safety. Mayo Clinic also notes that transplants are typically used only after other treatments have been tried, which is why breadth of non-surgical options matters as much as surgical skill.

The Evidence Behind Each Treatment Option: A Minnesota Patient’s Primer

The following overview summarizes what the evidence shows for each major option. Patients can use it in any consultation, regardless of provider.

Surgical Restoration: FUE vs. FUT

Follicular Unit Extraction (FUE) is the dominant harvesting method. ISHRS census data shows it is used in 85.4% of male and 68.2% of female surgical patients. FUE removes individual follicles, avoiding a linear scar and typically involving minimal downtime.

Follicular Unit Transplantation (FUT), or the strip method, remains appropriate for certain patients who need a higher graft yield in a single session. It is used in 12.5% of men and 30.0% of women.

According to the ISHRS, the average first-time FUE patient requires 2,347 grafts per session, and 67% achieve their desired result in a single procedure.

Mayo Clinic describes a hair transplant as a form of skin graft that rearranges existing hair. It is an effective, permanent treatment, but it involves significant recovery time and often requires multiple procedures.

Scalp Micropigmentation (SMP)

SMP is a non-surgical medical tattoo process that deposits micro-pigments to mimic the appearance of hair follicles. It is used for:

  • Scar camouflage
  • Density enhancement in thinning areas
  • A closely shaved head appearance

Treatment typically involves multiple sessions spaced several weeks apart. Scar camouflage can substantially reduce a scar’s visibility, while density simulation creates the illusion of fuller coverage rather than new hair. SMP works best as a complement to surgery, particularly for patients with transplant or injury scarring.

Medical Therapy: Finasteride and Minoxidil

Finasteride has strong clinical support. In men with vertex hair loss, it improved hair growth in 48% of recipients at one year and 66% at two years, compared with 7% on placebo. After two years, 83% of finasteride users had no further hair loss, versus 28% on placebo.

Minoxidil is the most common over-the-counter hair loss treatment and can regrow up to about 10% of lost hair.

Both have established FDA regulatory status, making them a baseline, evidence-backed starting point that providers should offer or at least discuss before surgical escalation.

Low-Level Laser Therapy (LLLT)

LLLT is one of only three FDA-cleared approaches for androgenetic alopecia, alongside minoxidil and finasteride, and it is the only one that requires no medication. At least 29 FDA-cleared LLLT devices are currently on the market, giving patients a benchmark to verify a provider’s device against FDA clearance databases.

LLLT is often used as supportive therapy for early-stage thinning or as a maintenance adjunct to surgical and medical treatment.

PRP (Platelet-Rich Plasma) Therapy: Evidence and Limitations

A meta-analysis of 21 studies with 628 participants found that PRP significantly enhances hair density and thickness in women, with a favorable safety profile. Other research found activated PRP effective at increasing hair density and minimizing recurrence versus placebo, though its effect on hair thickness was less consistent.

PRP is best viewed as a credible adjunct therapy, often paired with transplantation, rather than a standalone cure. Patients should ask providers for supporting literature.

Exosome Therapy: Promise, Popularity, and Regulatory Reality

The FDA has not approved any exosome product for hair loss or any other condition. Clinics offering exosome injections are administering an unapproved biologic, and the 2019 FDA safety notification tied unapproved exosome products to serious infections.

Patients should ask directly: “Is this FDA-approved, and if not, how is that disclosed to me in writing?” The answer is one of the clearest differentiators between providers that prioritize marketing trends and those that practice fully informed consent.

Minnesota Provider Credential Comparison: Applying the Framework

This section applies the three-question framework to major Minnesota providers using publicly documented credentials and service information. It is not a popularity ranking; it is a transparency audit that patients can replicate.

Hair Transplant Specialists (Eagan)

  • Credentials: Dr. Sharon Keene served as ISHRS President (2014–2015), one of the highest peer-recognized leadership roles in the field. She also received the ISHRS Platinum Follicle Award for research contributions. Dr. Roy Stoller serves as an author and examiner for board certification exams, and the team includes additional board-certified surgeons.
  • Treatment spectrum: FUE, FUT (including the practice’s Microprecision Follicular Grafting® technique), facial hair transplants, SMP, PRP, LLLT, finasteride, minoxidil, Alma TED ultrasound-based therapy, and exosome/stem cell therapies. This meets the full evidence-based spectrum standard under one roof.
  • Transparency consideration: Consistent with Question 2, patients should confirm during consultation how exosome and stem cell therapies are disclosed relative to FDA status.

Shapiro Medical Group (Minneapolis/Bloomington)

Published content from this practice is primarily surgeon-bio-driven rather than structured around a patient-facing credential or FDA-disclosure framework. Patients should independently verify ABHRS status for the treating physician, ask about treatment breadth, and request FDA disclosure specifics in writing.

Hair Restoration Institute of Minnesota (Bloomington)

Its published service list (FUE, FUT, facial hair restoration, PRP, growth factor therapy, exosomes, SMP, LLLT, prescription treatment, and European hair systems) appears to satisfy the full spectrum question on paper. However, published materials promote exosome therapy without clear FDA regulatory disclaimers. Patients should independently verify individual practitioner credentials, since business longevity or local recognition does not substitute for surgeon certification.

HairClub (Bloomington)

HairClub operates nationally and offers non-surgical, bundled regrowth programs combining at-home minoxidil topicals with laser therapy.

The framework gap is limited Minnesota-specific credential content and surgeon bios, which makes it harder to verify a local provider’s ABHRS or ISHRS standing. Patients should ask which licensed physician oversees surgical referrals or medical therapy prescribing at the local location.

Bosley (Minnetonka)

Bosley is a national chain offering combined surgical and non-surgical service bundles. It publishes limited local surgeon credential detail compared with independent Minnesota practices. Patients should directly verify the treating physician’s ABHRS status and FDA disclosure practices before committing.

Special Considerations for Women Seeking Hair Restoration in Minnesota

Women represent roughly 40% of hair loss sufferers and are the fastest-growing surgical segment, with a 16.5% increase in female surgical patients from 2021 to 2024.

Technical approaches differ. Strip harvesting is used more often in women (30.0%) than men (12.5%), reflecting different loss patterns and donor considerations. PRP also has a strong evidence base in women, with meta-analysis data showing significant improvements in density and thickness.

Women should confirm a provider’s specific experience diagnosing and treating female-pattern hair loss, not just overall procedure volume.

What Mayo Clinic and National Medical Authorities Recommend

Mayo Clinic’s guidance aligns closely with this framework:

  • Hair transplants are an effective, permanent treatment but involve significant recovery time and often multiple procedures.
  • Transplants are typically considered only after other treatments have been tried, so genuine non-surgical options matter.
  • Patients should work with a board-certified physician trained and experienced in hair loss treatment.

Because Mayo Clinic is headquartered in Rochester, these standards carry particular in-state relevance for Minnesota patients.

Red Flags and Questions to Ask During a Minnesota Consultation

Patients should bring this checklist to every consultation:

  1. What is the treating physician’s ABHRS Diplomate status or equivalent board certification? Generic “board-certified” claims are not enough.
  2. Is each recommended treatment FDA-approved or cleared? Request written disclosure, especially for exosomes or stem cell products.
  3. Does the practice offer the full evidence-based spectrum (medical therapy, LLLT, PRP, SMP, FUE, FUT), or only a narrow proprietary technique?
  4. Who will actually perform the procedure? Confirm the roles of physicians and technicians, along with their years of experience and training.
  5. What data or published outcomes support the recommendation? Testimonials and before-and-after photos should not be the only evidence.

A provider that hesitates on any of these questions warrants closer scrutiny.

Conclusion: Making an Informed Decision About Hair Restoration in Minnesota

The three-question framework (ABHRS/ISHRS credentials, FDA disclosure, and full treatment spectrum) gives Minnesota patients a repeatable way to evaluate any provider. Hair loss affects a large and diverse population, including men, women, and a growing share of younger adults, and it deserves the same diligence as any other medical decision.

Credential transparency, more than marketing claims, is the most reliable indicator of safe, effective, natural-looking results. Providers willing to be open about regulatory status and credentials demonstrate the accountability patients should expect.

Schedule a Credential-Transparent Consultation

Patients ready to apply this framework can schedule a consultation with Hair Transplant Specialists in Eagan, led by a team that includes former ISHRS President Dr. Sharon Keene. The practice offers FUE, FUT, SMP, PRP, LLLT, and medical therapy under one roof, allowing personalized evaluation based on diagnosis rather than a single technique.

Patients are encouraged to bring this guide’s checklist and ask every question on it.

Hair Transplant Specialists
2121 Cliff Dr., Suite 210, Eagan, MN 55122
Phone: (651) 393-5399
Website: INeedMoreHair.com

Office Hours:
Monday–Thursday: 9:00 AM – 5:00 PM
Friday: 9:00 AM – 3:00 PM
Saturday and Sunday: By appointment only